1. A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond. Issue 9 (13th July 2022) Authors: Shapira, Shiran; Ben Shimon, Marina; Hay‐Levi, Mori; Shenberg, Gil; Choshen, Guy; Bannon, Lian; Tepper, Michael; Kazanov, Dina; Seni, Jonathan; Lev‐Ari, Shahar; Peer, Michael; Boubas, Dimitrios; Stebbing, Justin; Tsiodras, Sotirios; Arber, Nadir Journal: EMBO molecular medicine Issue: Volume 14:Issue 9(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗